PRECEDE’s 8th Annual Meeting: Accelerating Progress Toward Early...
November 12, 2026
Estimated New Cases
in 2026
Estimated Deaths
in 2026
Our mission: to increase the 5 year survival rate for pancreatic cancer from 13% to 50%.
By making a donation to the PRECEDE Foundation, you become a vital part of the movement driving change. Together, we can make a difference and create a future where pancreatic cancer is not only detectable early but also preventable. Your donation allows us to have a meaningful impact on the lives of those affected by pancreatic cancer.
At PRECEDE’s second annual gala, guests raised $1.2 million to support the PRECEDE Consortium’s work to detect pancreatic cancer earlier, when it is most treatable.
PRECEDE proceeds go towards research to detect pancreatic cancers earlier, saving thousands of lives from the world’s deadliest cancer.
This revolutionary effort is for early detection, screening and prevention for pancreatic cancer.
To All Our Sponsors & Partners
